Amicus Therapeutics
FOLD
$7.42
Share price
2.06%
Change (1 day)
-17.19%
Change (1 year)
Market capitalization of Amicus Therapeutics (FOLD)
Market cap: $2.07 Billion
As of May 2022 Amicus Therapeutics has a market cap of $2.07 Billion. This makes Amicus Therapeutics the world's 3496th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Market cap history of Amicus Therapeutics from 2007 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $2.09 B | -34.8% |
| 2021 | $3.21 B | -46.51% |
| 2020 | $6.01 B | 141.86% |
| 2019 | $2.48 B | 37.12% |
| 2018 | $1.81 B | -24.17% |
| 2017 | $2.39 B | 238.25% |
| 2016 | $0.70 B | -41.67% |
| 2015 | $1.21 B | 52.54% |
| 2014 | $0.79 B | 445.88% |
| 2013 | $0.14 B | 9.49% |
| 2012 | $0.13 B | 11.58% |
| 2011 | $0.11 B | -26.5% |
| 2010 | $0.16 B | 80.19% |
| 2009 | $0.09 B | -49.27% |
| 2008 | $0.17 B | -25.77% |
| 2007 | $0.23 B |
End of Day market cap according to different sources
On May 19th, 2022 the market cap of Amicus Therapeutics was reported to be:
$2.07 Billion
$2.07 Billion
$2.06 Billion
$2.07 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Novo Nordisk NVO | $239.33 B | 11,412.97% | 🇩🇰 Denmark |
 Biogen BIIB | $28.27 B | 1,260.32% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $112.35 B | 5,304.99% | 🇬🇧 UK |
 Lexicon Pharmaceuticals
LXRX | $0.24 B | -87.98% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $0.38 B | -81.27% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $14.66 B | 605.52% | 🇺🇸 USA |